首页> 外文期刊>Human Molecular Genetics >OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.
【24h】

OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.

机译:常染色体显性视神经萎缩患者的OPA1突变和半显性遗传的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

We and others have shown recently that mutations in the OPA1 gene encoding a dynamin-related mitochondrial protein cause autosomal dominant optic atrophy (ADOA) linked to chromosome 3q28-q29. Here we report screening of the OPA1 gene in a sample of 78 independent ADOA families. OPA1 mutations were identified in 25 patients (detection rate 32.1%) including 16 novel mutations. We successfully amplified OPA1 cDNA prepared from leukocyte RNA of three patients, and found the amount of transcripts harboring the Arg366Stop mutation was significantly reduced compared with transcripts derived from the normal chromosome. Analysis of the distribution of OPA1 mutations in ADOA revealed that most missense mutations cluster within the putative GTPase domain, and that there is a preponderance of mutations, which result in premature translation termination. These observations support the notion that haploinsufficiency may represent a major pathomechanism for ADOA. In addition, we identified an ADOA patient who is a compound heterozygote for two OPA1 missense mutations. The fact that this patient is by far more severely affected than her simple heterozygotic parents and siblings implies that at least these OPA1 alleles behave semi-dominantly rather than purely dominantly. Clinical examination revealed considerable variability in disease expression among patients carrying OPA1 mutations and no strict correlation with either the position or the type of mutation.
机译:我们和其他人最近发现,编码与动力蛋白相关的线粒体蛋白的OPA1基因突变会导致常染色体显性视神经萎缩(ADOA),与染色体3q28-q29相关。在这里,我们报告在78个独立的ADOA家族样本中筛选OPA1基因。在25例患者中检出OPA1突变(检出率32.1%),其中包括16个新突变。我们成功扩增了三名患者白细胞RNA制备的OPA1 cDNA,发现带有Arg366Stop突变的转录本数量与正常染色体衍生的转录本相比明显减少。分析ADOA中OPA1突变的分布情况表明,大多数错义突变都聚集在假定的GTPase域内,并且存在大量突变,导致翻译提前终止。这些观察结果支持单倍剂量不足可能是ADOA的主要发病机制的观点。此外,我们确定了一个ADOA患者,该患者是两个OPA1错义突变的复合杂合体。该患者比其简单的杂合父母和兄弟姐妹受到的影响要大得多,这一事实表明,至少这些OPA1等位基因的行为表现为半显性而非纯显性。临床检查显示,携带OPA1突变的患者在疾病表达上存在很大差异,并且与突变的位置或类型均无严格关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号